A 3D-QSAR of Angiotensin II (AT1) Receptor Antagonists Based on Receptor Surface Analysis

Journal of Chemical Information and Computer Sciences

Volumn 44, Issue 1, 2004, Pages 210-220

  Datar, Prasanna A ^a   Desai, Prashant V ^a,b   Coutinho, Evans C ^a  

^a BOMBAY COLLEGE OF PHARMACY   (India)

^b UNIVERSITY OF MISSISSIPPI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ELECTROSTATIC ENERGY; RECEPTOR SURFACE ANALYSIS;

APPROXIMATION THEORY; BINDING ENERGY; CHEMICAL BONDS; ELECTROSTATICS; GENES; MATHEMATICAL MODELS; MUTAGENESIS; SURFACE CHEMISTRY; VAN DER WAALS FORCES;

PROTEINS;

ANGIOTENSIN I; ANGIOTENSIN RECEPTOR;

ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; DRUG ANTAGONISM; METABOLISM; QUANTITATIVE STRUCTURE ACTIVITY RELATION;

ANGIOTENSIN I; MODELS, MOLECULAR; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; RECEPTORS, ANGIOTENSIN;

EID: 1542426110     PISSN: 00952338     EISSN: None     Source Type: Journal    
DOI: 10.1021/ci0341520     Document Type: Article

References (47)

1. Dzau, V. J.; Pratt, R. E. Renin-Angiotensin System: Biology, Physiology and Pharmacology. In The Heart and Cardiovascular System; Fozzard, H. A., Haber, E., Jennings, R. B., Katz, A. M., Morgan, H. E., Eds.; Raven Press: New York, 1986; pp 1631-1662.
2. Joseph, M. P.; Maigret, B.; Bonnafous, J. C.; Marie, J.; Scheraga, H. A. A Computer Modeling Postulated Mechanism for Angiotensin II Receptor Activation. J. Protein Chem. 1995, 14, 381-398.
3. Nikiforovich, G. V.; Marshall, G. R. 3D Model for TM Region of the AT-1 Receptor in Complex with Angiotensin II Independently Validated by Site-Directed Mutagenesis Data. Biochem. Biophys. Res. Commun. 2001, 286, 1204-1211.
4. Laura, B.; Bravi, G.; Scolastico, C.; Vulpetti, A.; Salimbeni, A.; Todeschini, R. A 3D QSAR Approach to the Search for Geometrical Similarity in a Series of Nonpeptide Angiotensin II Receptor Antagonists. J. Comput.-Aided Mol. Des. 1994, 8, 211-220.
5. Laura, B.; Bravi, G.; Catalane, G.; Mabilia, M.; Salimbeni, A.; Scolastico, C. A 3D QSAR CoMFA Study of Non-peptide Angiotensin II Receptor Antagonists. J. Comput.-Aided Mol. Des. 1996, 10, 567-582.
6. Prendergast, K.; Adams, K.; Greenlee, W. J.; Nachbar, B.; Patchett, A. A.; Underwood, D. J. Derivation of a 3D Pharmacophore Model for the Angiotensin-II Site One Receptor. J. Comput.-Aided Mol. Des. 1994, 8, 491-512.
7. Datar, P.; Desai, P.; Coutinho, E.; Iyer, K. CoMFA and CoMSIA Studies of Angiotensin (AT1) Receptor Antagonists. J. Mol. Model. 2002, 8, 290-301.
8. Hahn, M. Receptor Surface Models. 1. Definition and Construction. J. Med. Chem. 1995, 38, 2080-2090.
9. Cramer, R. D.; Patterson, D. E. Bunce, J. D. Comparative Molecular Field Analysis (CoMFA). 1. Effect of Shape on Binding of Steroids to Carrier Proteins. J. Am. Chem. Soc. 1988, 110, 5959-5967.
10. Rogers, D.; Hopfinger, A. J. Application of Genetic Function Approximation to Quantitative Structure-Activity Relationships and Quantitative Structure-Property Relationships. J. Chem. Inf. Comput. Sci. 1994, 34, 854-866.
11. Holland, J. Adaptation in Artificial and Natural Systems; University of Michigan Press: Ann Arbor, MI, 1975.
12. Friedman, J. Multivariate Adaptive Regression Splines; Technical Report 102, Laboratory for Computational Statistics, Department of Statistics, Stanford University: Stanford, CA, 1988; revised 1990. Gasteiger, J.; Marsali, M. Tetrahedron Lett. 1978, 34, 3181.
13. Friedman, J. Multivariate Adaptive Regression Splines; Technical Report 102, Laboratory for Computational Statistics, Department of Statistics, Stanford University: Stanford, CA, 1988; revised 1990. Gasteiger, J.; Marsali, M. Tetrahedron Lett. 1978, 34, 3181.
14. Naylor, E. M.; Chakravarty, P. K.; Costello, A. C.; Chang, R. S.; Chen, T.; Faust, K. A.; Lotti, V. J.; Kivlighn, S. D.; Zingaro, G. J.; Siegl, P. K. S.; Pancras, C. W.; Carini, D. J.; Wexler, A. A.; Greenlee, W. J. Potent Imidazole Angiotensin II Antagonists; Acyl Sufonamides and Acyl Sulfamides as Tetrazole Replacements. Bioorg. Med. Chem. Lett. 1994, 4, 69-74.
15. Wallace, T. A.; Steven, M. H.; Greenlee, W. J.; Doss, G. A.; Chang, R. S. L.; Lotti, V. J.; Faust, K. A.; Chen, T.; Zingaro, G. J.; Kivlighn, S. D.; Siegl, P. K. S. Nonpeptide Angiotensin II Antagonists Derived from 1H-Pyrazole-5-carboxylates and 4-Aryl-1H-imidazole-5-carboxylates. J. Med. Chem. 1993, 36, 3595-3605.
16. 1 selective Angiotensin II Receptor Antagonist. J. Med. Chem. 1994, 37, 4068-4072.
17. (b) Mantlo, N. B.; Chakravarty, P. K.; Ondeyka, D. L.; Siegl, P. K. S.; Chang, R. S. L.; Lotti, V. J.; Faust, K. A.; Chen, T.; Schorn, T. W.; Sweet, C. S.; Emmert, S. E.; Patchett, A. A.; Greenlee, W. J. Potent, Orally Active Imidazo[4,5-b]pyridine Based Angiotensin II Receptor Antagonists. J. Med. Chem. 1991, 34, 2919-2922.
18. (c) Dhanoa, D. S.; Bagley, S. W.; Chang, R. S. L.; Lotti, V. J.; Chen, T.; Siegl, P. K. S. Chakravarty, P. K.; Patchett, A. A.; Greenlee, W. J. (Dipropylphenoxy)phenylacetic Acids: A New Generation of Non-peptide Angiotensin II Receptor Antagonists. J. Med. Chem. 1993, 36, 3738-3742.
19. (d) Dhanoa, D. S.; Bagley, S. W.; Chang, R. S. L.; Lotti, V. J.; Chen, T.; Siegl, P. K. S.; Zingaro, G. J.; Patchett, A. A.; Greenlee, W. J. Non-Peptide Angiotensin II Receptor Antagonists. 1. Design, Synthesis, and Biological Activity of N-Substituted Indoles and Dihydroindoles. J. Med. Chem. 1993, 36, 4230-4238.
20. 2 Subtypes. J. Med. Chem. 1994, 37, 4464-4478.
21. 2 Affinity. J. Med. Chem. 1994, 37, 2808-2824.
22. (c) Linda, L. C.; Wallace, T. A.; Flanagan, K. L.; Greenlee, W. J.; Chang, R. S. L.; Lotti, V. J.; Faust, K. A.; Chen, T.; Zingaro, G. J.; Kivlighn, S. D.; Siegl, P. K. S.; Bunting, P.; MacCoss, M.; Strelitz, R. A. Triazolinones as Nonpeptide Angiotensin II Antagonists. 1. Synthesis and Evaluation of Potent 2,4,5-Trisubstituted Triazolinones J. Med. Chem. 1993, 36, 2558-2568.
23. 2 Subtypes. J. Med. Chem. 1995, 38, 3741-3758.
24. Linda, L. C.; Wallace, T. A.; Cantone, C. L.; MacCoss, S. S.; Chang, R. S. L.; Lotti, V. J.; Faust, K. A.; Chen, T.; Strelitz, R. A.; Bunting, P.; Kivlighn, S. D.; Siegl, P. K. S. Nonpeptide Angiotensin II Antagonists Derived from 4H-1,2,4-Triazoles and 3H-Imidazo[1,2-b]-[1,2,4]triazoles. J. Med. Chem. 1993, 36, 591-609.
25. 1-Selective Angiotensin II Receptor Antagonists. Bioorg. Med. Chem. Lett. 1993, 3, 1293-1298.
26. (b) Bagley, S.: Greenlee, W. J.; Dhanoa, D. S.; Patchett, A. A. U.S. Pat. No. 5,175,164, 1992.
27. 2 Angiotensin II Antagonists: Quinazolinone AII Antagonists with Acylsulfonamide and Sulfonylcarbamate Acidic Functionalities. Bioorg. Med. Chem. Lett. 1994, 4, 81-86.
28. (a) Chakravarty, P. K.; Camara, V. J.; Chen, A.; Marcin, L. M.; Greenlee, W. J.; Patchett, A. A.; Chang, R. S. L.; Lotti, V. J.; Siegl, P. K. S. 200th National Meeting of the American Chemical Society; American Chemical Society,: Washington, DC, August 1990; pp 26-31.
29. (b) Chakravarty, P. K.; Patchett, A. A.; Camara, V. J.; Walsh, T. F.; Greenlee, W. J. Eur. Pat. Appl. 400,835, 1990.
30. (a) Ondeyka, D. L.; Mantlo, N. B.; Chakravarty, P. K.; Chen, A.; Camara, V. J.; Chang, R. S. L.; Lotti, V. J.; Siegl, P. K. S.; Patchett, A. A.; Greenlee, W. J. Joint Central-Great Lakes Regional Meeting of the American Chemical Society, Indianapolis, May 31, 1991.
31. (b) Chakravarty, P. K.; Greenlee, W. J.; Mantlo, N. B.; Patchett, A. A.; Walsh, T. F. Eur. Pat. Appl. 400,974, 1990.
32. Allen, E. E.; Huang, S. X.; Chang, R. S. L.; Lotti, V. J.; Siegl, P. K. S.; Patchett, A. A.; Greenlee, W. J. 202nd National Meeting of the American Chemical Society, New York, Aug. 25-30, 1991.
33. Patchett, A. A.; Mantlo, N. B.; Greenlee, W. J. U.S. Pat. No. 5,124,335, 1992.
34. Greenlee, W. J.; Johnston, D. B. R.; MacCoss, M.; Mantlo, N. B.; Patchett, A. A.; Chakravarty, P. K.; Walsh, T. F. U.S. Pat. No. 5,164,407, 1992.
35. Allen, E. E.; Greenlee, W. J.; Chakravarty, P. K.; Patchett, A. A.; Walsh, T. F. U.S. Pat. No. 5,100,897, 1992.
36. 2 Modeling Environment, Release 4.0; Accelrys Inc.: San Diego, CA, 1999.
37. Discover, v.98, Cerius2 Modeling Environment; Accelrys Inc.: San Diego, CA, 1999.
38. Lorensen, W. E.; Cline, H. E. Marching Cubes: A High Resolution 3-D Surface Construction Algorithm. Comput. Graphics (Proc. SIGGRAPH, 21) 1987, 4, 163-169.
39. SYBYL 6.7, Force Field Manual; Tripos Inc.: St Louis, MO; p 290 (Oct 2000).
40. Gasteiger, J.; Marsili, M. Iterative Partial Equalization of Orbital Electronegativity-A Rapid Access to Atomic Charges. Tetrahedron 1980, 36, 3219-3228.
41. Dauber-Osguthorpe, P.; Roberts, V. A.; Osguthorpe, D. J.; Wolff, J.; Genest, M.; Hagler, A. T. Structure and Energetics of Ligand Binding to Proteins: E. Coli Dihydrofolate Reductase-Trimethoprim, A Drug-Receptor System. Proteins: Struct., Fund. Genet. 1988, 4, 31-37.
42. Stewart, J. J. P. MOPAC: A Semiempirical Molecular Orbital Program. J. Comput.-Aided Mol. Des. 1990, 4, 1-105.
43. Rappé, A. K.; Goddard, W. A., III. Charge Equilibration for Molecular Dynamics Simulations. J. Phys. Chem. 1991, 95, 3358.
44. 2 User Guide, July 1998; Accelrys Inc.: San Diego, CA, 1998.
45. Hahn, M.; Rogers, D. Receptor Surface Models. 2. Application to Quantitative Structure-Activity Relationship Studies. J. Med. Chem. 1995, 38, 2091-2102.
46. Leger, C.; Politis, D. N.; Romano, J. P. Bootstrap Technology and Applications. Technometrics 1992, 34, 378-399.
47. Shi, L. M.; Fan, Y.; Myers, T. G.; O'Connor, P. M.; Paull, K. D.; Friend, S. H.; Weinstein, J. N. Mining the NCI Anticancer Drug Discovery Databases: Genetic Function Approximation for the QSAR Study of Anticancer Ellipticine Analogues. J. Chem. Inf. Comput. Sci. 1998, 38, 189-199.